↓ Skip to main content

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)

Overview of attention for article published in Frontiers in oncology, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
Published in
Frontiers in oncology, May 2022
DOI 10.3389/fonc.2022.824891
Pubmed ID
Authors

Gustavo R. Sarria, Grit Welzel, Martin Polednik, Frederik Wenz, Yasser Abo-Madyan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 29%
Student > Postgraduate 1 14%
Unknown 4 57%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 14%
Nursing and Health Professions 1 14%
Medicine and Dentistry 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2022.
All research outputs
#8,076,365
of 26,169,168 outputs
Outputs from Frontiers in oncology
#2,839
of 22,913 outputs
Outputs of similar age
#151,193
of 450,791 outputs
Outputs of similar age from Frontiers in oncology
#175
of 1,514 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,791 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,514 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.